Navigation Links
Raging Capital Calls Upon Board of Taro Pharmaceutical to Immediately Reject Sun Pharma's Acquisition Proposal
Date:2/27/2012

ROCKY HILL, N.J., Feb. 27, 2012 /PRNewswire/ -- Raging Capital Management, LLC ("Raging Capital"), one of the largest unaffiliated shareholders of Taro Pharmaceutical Industries Ltd. ("Taro") (Pink Sheets: TAROF), announced today that it delivered a letter to the Board of Directors of Taro demanding that it immediately reject the October 18, 2011 proposal of Sun Pharmaceutical Industries Ltd. to acquire all of the remaining outstanding shares of Taro at a price of $24.50 per share.  Raging Capital stated that it will hold each Taro director personally accountable and liable to the extent the Board accepts any acquisition proposal that undervalues the company. 

The full text of the letter follows: 

 February 27, 2012Taro Pharmaceutical Industries Ltd.

 14 Hakitor Street

 Haifa Bay 26110, Israel

 Attn:

Board of Directors:

  

Dilip Shanghvi

  

Sudhir Valia

  

Aalok Shanghvi

  

Dov Pekelman

  

Ilana Avidov-Mor

  

Dan Biran

  

James Kedrowski

 Dear Members of the Board:

Raging Capital Management, LLC is one of the largest unaffiliated shareholders of Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company").  In a letter to the Board of Directors dated November 3, 2011, we expressed to you our serious concerns regarding the grossly inadequate proposal of Sun Pharmaceutical Industries Ltd. ("Sun Pharma") to acquire all of the issued and outstanding shares of Taro at a price of $24.50 per share, in cash (the "Acquisition Proposal").  We are disappointed that you have still not responded to this letter.  Since then, we have read with great interest various public lette
'/>"/>

SOURCE Raging Capital Management, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research
2. Raging Capital Sends Letter to Taro Pharmaceutical Board of Directors in Opposition to Inadequate Acquisition Offer by Sun Pharmaceutical
3. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
4. SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
5. comScore Announces Availability of Media Planning Tool Leveraging Behavioral Insights into Online Usage Habits of Doctors
6. Power Wheelchair From Medicare Helps Save Elderly Alabama Woman From Raging Fire That Destroyed Her Home of 40 Years
7. Stimatix GI Reports Encouraging Interim Results
8. Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature
9. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
10. Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
11. AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimers Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Larry J. ... CVS ), will speak before the National Press Club ... discuss the company,s recent move to stop selling tobacco products ... the future of health. "Dramatic changes in our ... care providers and government," Merlo has said. "CVS Health has ...
(Date:9/19/2014)... 19, 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ... received and approved all parts required to build ... begun to manufacture the new PCT-based instrument system.  ... ready for shipment by mid-October and that additional ... a rate of about one per week thereafter.  ...
(Date:9/19/2014)... MINNEAPOLIS and ORLANDO, Fla. ... data supporting Inspire therapy continues to grow, with the ... paper published on-line in Otolaryngology – Head ... therapy causes a worsening of both objective and subjective ... to directly attribute Inspire therapy for the reduction in ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
(Date:9/21/2014)... September 21, 2014 The Illinois ... will host a statewide symposium ( tinyurl.com/ILBHC14 ) ... and their Families. Sponsored by the VNA Foundation, ... Cash Grant, and Health & Disability Advocates, the ... the Hilton Hotel in Springfield, IL. The ...
(Date:9/21/2014)... SUNDAY, Sept. 21, 2014 (HealthDay News) -- Young women ... and know which foods they should eat. But they ... nutritional choices, according to a new study. ... the University of Illinois,s Peer Education Exercising and Eating ... what would they choose to eat if they were ...
(Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
(Date:9/21/2014)... experienced review website in the global market, Top10BestSEOHosting.com, has ... that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost are ... been a boom in websites in recent years, and ... the number of web hosting companies that offer a ... (Virtual Private Server) is the method of partitioning a ...
(Date:9/21/2014)... 2014 Faculty and staff at Garrison Forest ... in Owings Mills, Md., kicked off the academic year by ... GFS is the first independent school to receive the bands— ... even sleep patterns— as part of a pilot program with ... walking specialty chain. The Vivofit bands are just one tool ...
Breaking Medicine News(10 mins):Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2
... to Participating in Conspiracy , WASHINGTON, Oct. 9 ... in connection with an alleged $2.3 million Medicare fraud ... that purported to specialize in providing injection and infusion ... A. Breuer, U.S. Attorney for the Eastern District of ...
... , PRINCETON, N.J., Oct. 5 In conjunction with its third quarter ... 21, 2009), Covance Inc. (NYSE: CVD ) is pleased to invite ... broadcast live over the Internet on Thursday, October 22, 2009 at 9:00 ... Quarter 2009 Earnings Webcast and Slide Presentation, When: ...
... researchers say , FRIDAY, Oct. 9 (HealthDay News) -- Human ... cases of a rare type of head and neck cancer, ... tumor that grows behind the nose and at the top ... of every 100,000 people in the United States. According to ...
... ... CMS-mandated Home Health Agency Satisfaction Reporting Set to Begin , , ... South Bend, IN (Vocus) October 9, ... and a new report released today finds an upward trend in overall home care ...
... ... 8th Annual Electronic Submissions Conference from November 17- 19, 2009 in San Diego, CA., ... Horsham, PA (Vocus) October 8, ... Electronic Submissions Conference from November 17- 19, 2009 in San Diego, CA., , , ...
... type 1 diabetes, widens net while increasing accuracy of ... A sophisticated computational algorithm, applied to a large ... conventional methods in assessing individual risk for type 1 ... M.D., Ph.D., director of the Center for Applied Genomics ...
Cached Medicine News:Health News:Detroit Clinic Owner, Doctor and Office Manager Indicted in Medicare Infusion Fraud Scheme 2Health News:Detroit Clinic Owner, Doctor and Office Manager Indicted in Medicare Infusion Fraud Scheme 3Health News:Detroit Clinic Owner, Doctor and Office Manager Indicted in Medicare Infusion Fraud Scheme 4Health News:HPV Tied to Rare Head-and-Neck Cancer 2Health News:Authoritative Report on Home Health Care Experiences Released By Press Ganey 2Health News:Authoritative Report on Home Health Care Experiences Released By Press Ganey 3Health News:DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 2Health News:DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 3Health News:Gene Data Tool Advances Prospects for Personalized Medicine 2Health News:Gene Data Tool Advances Prospects for Personalized Medicine 3
... LH Ovulation Predicting Test is a qualitative ... Hormone (hLH) in human urine to predict ... by the elevation of human luteinizing hormone ... period starts, hLH has a brief, significant ...
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
... The Shandon Varistain 24-4 ... stainer designed to offer simplicity ... cytology staining applications. It is ... load and continuous throughput. ...
The Shandon Linistat Linear Stainer is a compact answer to H&E frozen section protocols, with a footprint that fits on top of most cryostas to streamline workflow during frozen sectioning....
Medicine Products: